Xunjie Guangyuan

Xunjie Guangyuan operates engages in the research and development of near-infrared spectroscopy analysis instruments.

Health and bio

Xunjie Guangyuan has no funding amount on record yet; its latest known round is Series B+ (Sep 2026). Recent Funding first saw it on October 4, 2026.

Raise history

1. September 28, 2026
   Series B+ · amount undisclosed
   CCuiwei Fund, SShenzhen Capital Group, VV Fund Management
   Source: chinaventure.com.cn

Investors

• CCuiwei Fund
• FFortune Venture Capital
• GGenesis Capital VC
• SShenzhen Capital Group
• VV Fund Management
• XXianting Fund

Related bio health companies

• TTriGemX Bio$94M · Oct 1, 2026
• SSedMed$4M · Oct 1, 2026
• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• BBiotia$9M · Oct 1, 2026
• RR1 Therapeutics$80.5M · Sep 30, 2026
• LLinux Laboratories$70M · Sep 30, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/xunjie-guangyuan.